| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/19/2009 | WO2009023246A2 Pluripotent adult stem cells |
| 02/19/2009 | WO2009023194A2 Hormone responsive tissue culture system and uses thereof |
| 02/19/2009 | WO2009023161A1 Methods of producing pluripotent stem-like cells |
| 02/19/2009 | WO2009022907A2 A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
| 02/19/2009 | WO2009022656A1 Recombinant mammalian cells, method of producing recombinant mammalian cells and method of producing target protein |
| 02/19/2009 | WO2009022339A1 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
| 02/19/2009 | WO2009022158A1 Thermophilic micro-organisms for ethanol production |
| 02/19/2009 | WO2009021995A1 Method for in vitro amplification of regulatory t-cells |
| 02/19/2009 | WO2009021982A1 Dendritic cells |
| 02/19/2009 | WO2009021853A1 Eukaryotic promoters for gene expression |
| 02/19/2009 | WO2009021333A1 Blood vessel extraction from umbilical cord |
| 02/19/2009 | WO2009021288A1 Improved gene silencing methods |
| 02/19/2009 | WO2009021285A1 Barley with low levels of hordein |
| 02/19/2009 | WO2009021276A1 Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof |
| 02/19/2009 | WO2009004664A3 Immortalized cell line of murine mesenchymal stem cells, method for preparation and uses thereof |
| 02/19/2009 | WO2008157324A3 Peptide linked cell matrix materials for stem cells and methods of using the same |
| 02/19/2009 | WO2008154267A3 Dose profile measurement system for clinical proton fields |
| 02/19/2009 | WO2008143630A3 Recombinant hydrogen-producing cyanobacterium and uses thereof |
| 02/19/2009 | WO2008105931A3 Mdck cell lines supporting viral growth to high titers and bioreactor process using the same |
| 02/19/2009 | WO2008084401A3 Composition and method for enabling proliferation of pluripotent stem cells |
| 02/19/2009 | WO2007084585A3 Non-human primate embryonic stem and germ cells: methods of use and methods of making same |
| 02/19/2009 | WO2006112869A3 Modulation of cytokine signaling regulators and applications for immunotherapy |
| 02/19/2009 | WO2005117569A3 A method for producing direct in vitro flowering and viable seed from cotyledon, radicle, and leaf explants and plants produced therefrom |
| 02/19/2009 | US20090049574 Use in altering root development, screening for herbicides; may enhance food production, especially in arid climates |
| 02/19/2009 | US20090049568 Method for preventing dehiscence and altering plant lignification |
| 02/19/2009 | US20090049565 Methods to Identify Soybean Aphid Resistant Quantitative Trait Loci in Soybean and Compositions Thereof |
| 02/19/2009 | US20090049563 Using cytosine deaminases to diminish retroelement transfer from pigs to humans |
| 02/19/2009 | US20090049561 Non-human animal exhibiting bone metastasis of tumor cells |
| 02/19/2009 | US20090048435 Oligonucleotide modulation of cell adhesion |
| 02/19/2009 | US20090048222 Triaza Compound Immunoregulatory Agents |
| 02/19/2009 | US20090048207 Hydrazide-containing cftr inhibitor compounds and uses thereof |
| 02/19/2009 | US20090048191 Therapeutic molecules for modulating stability of vegf |
| 02/19/2009 | US20090048187 Chemopreventive, Anticancer and Anti-Inflammatory Effects of Pinoresinol-Rich Olives |
| 02/19/2009 | US20090048183 Iap binding compounds |
| 02/19/2009 | US20090048170 Target for anti-angiogenesis therapy |
| 02/19/2009 | US20090048169 Identification of Crmp4 as a Convergent Regulator of Axon Outgrowth Inhibition |
| 02/19/2009 | US20090048168 Inhibitors of bcl-2 |
| 02/19/2009 | US20090048163 Nucleic acid and protein sequences of asporins |
| 02/19/2009 | US20090048161 Cytokine receptor modulators and uses thereof |
| 02/19/2009 | US20090048122 Stabilized polypeptide compositions |
| 02/19/2009 | US20090048111 Rna interference using a universal target |
| 02/19/2009 | US20090047742 Inhibition of mRNA Interferase-Induced Apoptosis in BAK-Deficient and BAK- and Bax-Deficient Mammalian Cells |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047740 Culture aid for cells and tissues |
| 02/19/2009 | US20090047739 Direct Differentiation Method for Making Cardiomyocytes from Human Embryonic Stem Cells |
| 02/19/2009 | US20090047738 Feeder cell derived from tissue stem cell |
| 02/19/2009 | US20090047737 Human LY6-Big Molecules and Methods of Use |
| 02/19/2009 | US20090047736 Human T1R2 nucleic acid sequences and polypeptides |
| 02/19/2009 | US20090047735 Antibodies Against Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 02/19/2009 | US20090047728 Adenoviral vectors for influenza virus production |
| 02/19/2009 | US20090047703 ERG-1 Peptides and Polynucleotides and Their Use in the Treatment and Diagnosis of Disease |
| 02/19/2009 | US20090047675 Compositions and methods for indentifying transforming and tumor suppressor genes |
| 02/19/2009 | US20090047668 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 02/19/2009 | US20090047384 Lipolytic enzyme variants |
| 02/19/2009 | US20090047339 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/19/2009 | US20090047335 Anti-angiogenic peptides and methods of use thereof |
| 02/19/2009 | US20090047325 Xenotransplant for cns therapy |
| 02/19/2009 | US20090047322 Degradable Hydrophilic Block Copolymers with Improved Biocompatibility for Soft Tissue Regeneration |
| 02/19/2009 | US20090047302 Chimaeric Human Papillomavirus 16 L1 Virus Like Particles and a Method for Preparing the Particles |
| 02/19/2009 | US20090047299 Modified alpha-galactosyl ceramides for staining and stimulating natural killer t cells |
| 02/19/2009 | US20090047295 Methods and Compositions for Reducing Stemness in Oncogenesis |
| 02/19/2009 | US20090047290 Monoclonal antibodies against beta3 integrins |
| 02/19/2009 | US20090047287 Modulation of bone formation |
| 02/19/2009 | US20090047286 H2n3 influenza a viruses and methods of use |
| 02/19/2009 | US20090047285 Compositions and methods for diagnosing and treating cancer |
| 02/19/2009 | US20090047283 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/19/2009 | US20090047280 Antibody inhibiting infection of papillomavirus |
| 02/19/2009 | US20090047274 Diagnostic and therapeutic target cdc2l6 proteins for neurodegenerative diseases |
| 02/19/2009 | US20090047273 Method For Production of Recombinant Human Thrombin ['644] |
| 02/19/2009 | US20090047269 Metabolomic cancer targets |
| 02/19/2009 | US20090047263 Nuclear reprogramming factor and induced pluripotent stem cells |
| 02/19/2009 | US20090047262 Expression of class II transactivator fusion proteins for control of tumor growth |
| 02/19/2009 | US20090047260 Keratin biomaterials for cell culture and methods of use |
| 02/19/2009 | US20090047257 Novel cell populations and uses thereof |
| 02/19/2009 | US20090047249 Modulators of toll-like receptor 7 |
| 02/19/2009 | US20090047240 Chaperonin 10-induced immunomodulation |
| 02/19/2009 | US20090047221 Compounds and compositions useful in the treatment of neoplasia |
| 02/19/2009 | US20090047211 Anti-mesothelin antibodies useful for immunological assays |
| 02/19/2009 | DE102007036853A1 Single-piece device for applying and manipulating tissue transplant e.g. mucous membrane-, skin- and connective tissue transplants useful in plastic aesthetical gum surgery, has a bearing surface, and surfaces having sterilizable material |
| 02/19/2009 | CA2697265A1 Method of treating autoimmune disease with mesenchymal stem cells |
| 02/19/2009 | CA2696277A1 Thermophilic micro-organisms for ethanol production |
| 02/19/2009 | CA2696250A1 Barley with low levels of hordeins |
| 02/19/2009 | CA2696047A1 A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
| 02/19/2009 | CA2695999A1 Kappa-carrageenase and kappa-carrageenase-containing compositions |
| 02/19/2009 | CA2695455A1 Improved gene silencing methods |
| 02/18/2009 | EP2025757A2 Polymeric immunoglobulin receptor-mediated gene transfer |
| 02/18/2009 | EP2025754A2 Moraxella (Branhamella) catarrhalis antigens |
| 02/18/2009 | EP2025749A1 Humanized anti-human osteopontin antibody |
| 02/18/2009 | EP2025747A1 Method for in-vitro amplification of regulatory T-cells |
| 02/18/2009 | EP2025746A1 Dendritic cells |
| 02/18/2009 | EP2025745A1 Method for preparing cells for engraftment |
| 02/18/2009 | EP2025686A2 Alpha anticholine kinase monoclonal antibodies and their use in analytical techniques for the diagnosis of cancer and the preparation of medicinal products |
| 02/18/2009 | EP2025657A2 Method for manufacturing carbon based shapes and their use as cell culture bearing and cultivation systems |
| 02/18/2009 | EP2025353A2 Injectable polysaccharide-cell compositions |
| 02/18/2009 | EP2024748A2 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma |
| 02/18/2009 | EP2024516A2 Perforin-2 proteins |
| 02/18/2009 | EP2024502A1 Method for selection of transformed cells |
| 02/18/2009 | EP2024493A2 Methods of selecting stem cells and uses thereof |
| 02/18/2009 | EP2024492A2 Differentiation of primate pluripotent cells to hepatocyte-lineage cells |
| 02/18/2009 | EP2024392A2 Stabilized polypeptide compositions |